Superior and effective microbiome therapeutics

About us

CHAIN Biotechnology Ltd develops Clostridium-based microbial technology for high-value healthcare products. We produce novel 2nd generation live biotherapeutic products for chronic gut-related diseases.


Our Clostridium Assisted Drug Delivery (CADD™) platform is a targeted, robust and versatile method of delivering therapeutic bioactives to the gut in a safe, proven and affordable way.

Clinical Focus

We target inflammatory bowel disease with a focus on Ulcerative Colitis. Our live biotherapeutic platform is based on a Clostridium strain engineered to produce the anti-inflammatory β-hydroxybutyrate.